Tesaro: Losing It’s Edge? By: Stocks to Watch August 18, 2017 at 16:39 PM EDT U.S. regulators expanded use of AstraZeneca’s ovarian cancer drug Lynparza. What does that mean for rival Tesaro? Read More >>
